Structure (Finasteride Tab 8562 1)
Finasteride Tablet
Product Images NDC 0615-8562
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 0615-8562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Finasteride Tab 8562 2)
Figure2 (Finasteride Tab 8562 3)
Figure3 (Finasteride Tab 8562 4)
Figure4 (Finasteride Tab 8562 5)
Figure5 (Finasteride Tab 8562 6)
Principal Display Panel (Finasteride Tab 8562 7)
This is a description of Finasteride tablets containing 5 mg. It includes information about the manufacturer, Dr. Reddy's, and packaging details from Vangard in Glasgow, Kentucky. The warning on the package advises against use by women and children, especially pregnant women. The storage conditions, dosage instructions, and the fact that it is for institutional use only are also mentioned. Additionally, it provides details on the tablet composition, including the presence of film coating, and advises on handling precautions. The text also mentions package inserts for full prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
